Open Access Green as soon as Postprint is submitted to ZB.
Estimation of a possible tumorigenic risk of styrene from daily intake via food and ambient air.
Toxicol. Lett. 126, 1-18 (2002)
Concerns of a tumorigenic risk of styrene (ST) originate from the findings that styrene (ST) is metabolized to the genotoxic, intermediate styrene-7,8-oxide (SO). Therefore, it was hypothesized that results of animal long-term studies with ST and SO together with the SO tissue burden are sufficient for conducting a 'worst case' estimate of the tumorigenic risk of ST. On this basis we predicted the excess human lifetime risk for lung tumors (p(HPS)) and the highest possible risk for other systemic tumors (p(HPS)) resulting from daily intake of ST via food and ambient air. As measures for p(EXL) the mean lifetime concentration of SO in the transitional zone of the lung and for p(HPS) the mean lifetime concentration of SO in blood were calculated using a physiological toxicokinetic model. For a daily oral intake of 12 mug ST, p(EXL) was obtained to be between 5 x 10(-9) and 2 x 10(-8) and p(HPS) to be between 7 x 10(-9) and 2 x 10(-8). Lifetime risks calculated for continuous exposure to 3 mug/m(3) ST in ambient air were between 8 x 10(-7) and 3 x 10(-6). (P-EXL) and between 2 x 10(-8) and 4 x 10(-8) (p(HPS)). Although these values indicate very low risks, the actual risks are expected to be even by far smaller. This is discussed in detail for lung tumorigenesis.
Impact Factor
Scopus SNIP
1.587
0.000
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Styrene; Styrene-7,8-oxide; Tumorigenic risk; Toxicokinetics; Mouse; Rat; Human; Oral intake; Inhalation exposure; Rodent bioassay; Species extrapolation; Food; Physiological toxicokinetic model
Language
english
Publication Year
2002
HGF-reported in Year
0
ISSN (print) / ISBN
0378-4274
e-ISSN
1879-3169
Journal
Toxicology Letters
Quellenangaben
Volume: 126,
Pages: 1-18
Publisher
Elsevier
Publishing Place
Amsterdam
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Enabling and Novel Technologies
PSP Element(s)
G-505200-002
Erfassungsdatum
2002-11-05